United Arab Emirates MOHAP approves Biomerica’s Fortel PSA Screening Test

Biomerica (BMRA) announced that its Fortel Prostate Specific Antigen Screening Test has received approval from the United Arab Emirates Ministry of Health and Prevention. The Fortel PSA Screening Test is a user-friendly diagnostic tool that provides accurate results in just 10 minutes using a simple finger-prick blood sample. By measuring elevated PSA levels, a recognized early marker of prostate disease, the test can enable early detection of prostate cancer and other prostate-related conditions. This rapid and accessible approach aims to enhance proactive health management, reduce the burden on healthcare systems, and improve patient outcomes.